drs. M. Nijland

Research

Publications
  1. MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavourable prognosis

    Vermaat, J. S., Somers, S. F., de Wreede, L. C., Kraan, W., de Groen, R. A. L., Schrader, A. M. R., Kerver, E. D., Scheepstra, C. G., Beerenschot, H., Deenik, W., Wegman, J., Broers, R., de Boer, J-P. D., Nijland, M., van Wezel, T., Veelken, H., Spaargaren, M., Cleven, A. H., Kersten, M. J. & Pals, S. T., 2019, In : Haematologica. 33 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study

    Bromberg, J. E. C., Issa, S., Bakunina, K., Minnema, M. C., Seute, T., Durian, M., Cull, G., Schouten, H. C., Stevens, W. B. C., Zijlstra, J. M., Baars, J. W., Nijland, M., Mason, K. D., Beeker, A., van den Bent, M., Beijert, M., Gonzales, M., de Jong, D. & Doorduijn, J. K., Feb-2019, In : Lancet Oncology. 20, 2, p. 216-228 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (28) »

Press / Media
  1. Medtalks:Diffuus Grootcellig B-cellymfoom 2018

    Marcel Nijland

    01/10/2018

    1 media contribution

    Press/Media: Expert CommentProfessional

View all (1) »

View graph of relations

ID: 59823087